secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2022-01-04T23:59:59+00:00
Accession:  0000899923-22-000006
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics CSO Jerry Lanchbury to retire effective Jan 14, 2022
--------------------------------------------------------------------

- Dr. Jerry Lanchbury notified retirement as Chief Scientific Officer.
- Retirement effective January 14, 2022.
- Company expects to enter a separation and consulting agreement (terms to be filed later).
- No replacement has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992322000006/0000899923-22-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992322000006/mygn-20220103.htm
  HTML page:      https://secwatch.observer/filing/0000899923-22-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer